ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
Keros Therapeutics Inc

Keros Therapeutics Inc (KROS)

12.48
-0.34
(-2.65%)
종가: 15 1월 6:00AM
12.48
-0.04
( -0.32% )
시간외 거래: 6:19AM

개인 투자자를 위한 전문가급 도구.

주요 통계 및 세부정보

가격
12.48
매수가
12.40
매도가
12.65
거래량
1,132,037
12.215 일간 변동폭 13.08
12.3501 52주 범위 73.00
market_cap
전일 종가
12.82
개장가
12.99
최근 거래 시간
3
@
12.64
마지막 거래 시간
07:02:00
재정 규모
US$ 14,165,073
VWAP
12.5129
평균 볼륨(3m)
1,014,895
발행 주식
40,507,409
배당수익률
-
주가수익률
-3.31
주당순이익(EPS)
-3.78
매출
151k
순이익
-152.99M

Keros Therapeutics Inc 정보

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's protein therapeutic product candida... Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
본부
Dover, Delaware, USA
설립됨
-
Keros Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker KROS. The last closing price for Keros Therapeutics was US$12.82. Over the last year, Keros Therapeutics shares have traded in a share price range of US$ 12.3501 to US$ 73.00.

Keros Therapeutics currently has 40,507,409 shares in issue. The market capitalisation of Keros Therapeutics is US$519.30 million. Keros Therapeutics has a price to earnings ratio (PE ratio) of -3.31.

KROS 최신 뉴스

Keros Therapeutics Announces Update on the Phase 2 TROPOS Trial

Keros will host an update call and webcast today, December 12, 2024, at 8:00 a.m. ET LEXINGTON, Mass., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”...

Keros Therapeutics Presents Clinical Data from its Elritercept Program at the 66th American Society of Hematology Annual Meeting and Exposition

Elritercept demonstrated a durable transfusion independence in lower-risk myelodysplastic syndromes, including in patients with high transfusion burden, with a median duration of response of 134.1...

Keros Therapeutics Announces Global License Agreement with Takeda to Advance Elritercept

Keros Therapeutics to receive upfront payment of $200 million and is eligible to receive development, approval and commercial milestone payments with the potential to exceed $1.1 billion and...

Keros Therapeutics Announces Participation at Upcoming Healthcare Conferences

LEXINGTON, Mass., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-3.29-20.862396956215.7716.4912.3501137186414.07013967CS
4-6.61-34.625458355219.0919.3112.3501120218816.0410061CS
12-47.31-79.126944305159.7972.3712.3501101489528.84005545CS
26-35.56-74.021648626148.0472.3712.350164202636.00043363CS
52-39.03-75.771694816551.517312.350150063943.13516916CS
156-36.6-74.572127139449.087312.350131594942.27470131CS
260-7.62-37.910447761220.188.812.350125067244.22886202CS

KROS - Frequently Asked Questions (FAQ)

What is the current Keros Therapeutics share price?
The current share price of Keros Therapeutics is US$ 12.48
How many Keros Therapeutics shares are in issue?
Keros Therapeutics has 40,507,409 shares in issue
What is the market cap of Keros Therapeutics?
The market capitalisation of Keros Therapeutics is USD 519.3M
What is the 1 year trading range for Keros Therapeutics share price?
Keros Therapeutics has traded in the range of US$ 12.3501 to US$ 73.00 during the past year
What is the PE ratio of Keros Therapeutics?
The price to earnings ratio of Keros Therapeutics is -3.31
What is the cash to sales ratio of Keros Therapeutics?
The cash to sales ratio of Keros Therapeutics is 3.38k
What is the reporting currency for Keros Therapeutics?
Keros Therapeutics reports financial results in USD
What is the latest annual turnover for Keros Therapeutics?
The latest annual turnover of Keros Therapeutics is USD 151k
What is the latest annual profit for Keros Therapeutics?
The latest annual profit of Keros Therapeutics is USD -152.99M
What is the registered address of Keros Therapeutics?
The registered address for Keros Therapeutics is 850 NEW BURTON ROAD, SUITE 201, DOVER, DELAWARE, 19904
What is the Keros Therapeutics website address?
The website address for Keros Therapeutics is www.kerostx.com
Which industry sector does Keros Therapeutics operate in?
Keros Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
HSDTHelius Medical Technologies Inc
US$ 1.03
(48.84%)
1.34M
VMARVision Marine Technologies Inc
US$ 1.77
(26.43%)
8.61M
ERNAEterna Therapeutics Inc
US$ 0.5746
(25.46%)
5.72M
MASS908 Devices Inc
US$ 2.39
(20.71%)
679.06k
RPIDRapid Micro Biosystems Inc
US$ 1.30
(19.27%)
31.35k
RIMEAlgorhythm Holdings Inc
US$ 0.0641
(-18.03%)
9.21M
NCRANocera Inc
US$ 0.9005
(-15.84%)
70.13k
CPIXCumberland Pharmaceutical Inc
US$ 2.3001
(-13.85%)
73.34k
XRTXXORTX Therapeutics Inc
US$ 1.13
(-11.02%)
211.28k
TOIOncology Institute Inc
US$ 0.3301
(-10.76%)
14.12k
RIMEAlgorhythm Holdings Inc
US$ 0.0641
(-18.03%)
9.21M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.0683
(10.34%)
9.14M
RGTIRigetti Computing Inc
US$ 8.88
(-0.78%)
9.12M
VMARVision Marine Technologies Inc
US$ 1.77
(26.43%)
8.61M
ERNAEterna Therapeutics Inc
US$ 0.5746
(25.46%)
5.72M

최근 히스토리

Delayed Upgrade Clock